Galmed Pharmaceutica (GLMD)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Operating Expenses | 6,278 | 7,492 | 17,651 | 32,881 | 30,210 |
| Operating Income | -6,278 | -7,492 | -17,651 | -32,881 | -30,210 |
| Other Income | -1,239 | 580 | -215 | 414 | 1,439 |
| Pre-tax Income | -7,517 | -6,912 | -17,866 | -32,467 | -28,771 |
| Net Income Continuous | -7,517 | -6,912 | -17,866 | -32,467 | -28,771 |
| Net Income | $-7,517 | $-6,912 | $-17,866 | $-32,467 | $-28,771 |
| EPS Basic Total Ops | -8.08 | -30.00 | -127.85 | -237.58 | -242.98 |
| EPS Basic Continuous Ops | -8.08 | -29.95 | -127.97 | -237.56 | -243.33 |
| EPS Diluted Total Ops | -8.08 | -30.00 | -127.85 | -237.58 | -242.98 |
| EPS Diluted Continuous Ops | -8.08 | -29.95 | -127.97 | -237.56 | -243.33 |
| EPS Diluted Before Non-Recurring Items | -8.08 | -30.01 | -127.79 | -237.58 | -242.98 |
| EBITDA(a) | $-6,212 | $-7,442 | $-17,618 | $-32,718 | $-30,081 |